Ayfer Kamali Polat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayfer Kamali Polat has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ismail Alper Tarim
Department of General Surgery, Samsun Ondokuz Mayıs University, İstanbul, Türkiye
3 shared publications - Ufuk Karabacak
Department of General Surgery, Faculty of Medicine, Ondokuz Mayıs University, Samsun 55200, Türkiye
3 shared publications - Ahmet Veysel Polat
Department of Radiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkiye
2 shared publications - Aysu Basak Ozbalci
Department of Radiology, Ondokuz Mayıs University School of Medicine, Samsun, Turkey
2 shared publications - Hamza Çınar
Department of Surgery, Division of Gastrointestinal Surgery, Pamukkale University School of Medicine, Denizli 20010, Türkiye
2 shared publications - Kagan Karabulut
Department of General Surgery, Ondokuz Mayıs University School of Medicine, Samsun, Turkey
2 shared publications
Latest Publications
- Open Access
- 11 March 2023
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (1) , 13-22
Fournier’s Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases
Objective: Fournier’s gangrene (FG) is a rare necrotizing fasciitis affecting genital and perianal areas. This study aimed to provide data on predicting factors, mortality rates, and factors affecting mortality in comparison of survivors and non-survivors in patients with FG. Materials and Methods: This study included a retrospective analysis of patients diagnosed with FG between 2008 and 2018. Results: A total of 97 patients with FG were included in this study. Of the patients, 72 (74%) were male. The mean age was 56.03±13.92 years, and the median was 57 (21-90). The mortality rate was 21.6%. The most frequently isolated microorganism from tissue and blood cultures was Escherichia coli (43%-42%). The median Fournier’s Gangrene Severity Index (FGSI) and Uludağ FGSI (UFGSI) scores were 4 (0-20) and 5 (1-22), respectively. In the univariate model, mortality risk increases 7.18 times (p=0.001) in patients with two or more comorbidities, 1.31 times as the FGSI score increases (ppp=0.003); as the platelet count increased, mortality risk decreased (odds ratio [OR]=0.99; p=0.02). The mortality risk of those hospitalized in the intensive care unit (ICU) was 16.5 times higher than those followed in the ward (p<0.001). In the multivariate model, this ratio was 6.49. Conclusion: We concluded that FGSI and UFGSI scores could be used to predict mortality. Management of FG requires a multidisciplinary approach. Empiric treatment should include carbapenems and be de-escalated once getting the culture results. Authors from different centers should report their experiences to help reveal the ideal treatment and evaluate the consequences. Keywords: Fournier’s gangrene, necrotizing fasciitis, severity index, FGSI, UFGSI
- 11 March 2023
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (1) , 13-22
Open AccessFournier’s Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases
Objective: Fournier’s gangrene (FG) is a rare necrotizing fasciitis affecting genital and perianal areas. This study aimed to provide data on predicting factors, mortality rates, and factors affecting mortality in comparison of survivors and non-survivors in patients with FG. Materials and Methods: This study included a retrospective analysis of patients diagnosed with FG between 2008 and 2018. Results: A total of 97 patients with FG were included in this study. Of the patients, 72 (74%) were male. The mean age was 56.03±13.92 years, and the median was 57 (21-90). The mortality rate was 21.6%. The most frequently isolated microorganism from tissue and blood cultures was Escherichia coli (43%-42%). The median Fournier’s Gangrene Severity Index (FGSI) and Uludağ FGSI (UFGSI) scores were 4 (0-20) and 5 (1-22), respectively. In the univariate model, mortality risk increases 7.18 times (p=0.001) in patients with two or more comorbidities, 1.31 times as the FGSI score increases (ppp=0.003); as the platelet count increased, mortality risk decreased (odds ratio [OR]=0.99; p=0.02). The mortality risk of those hospitalized in the intensive care unit (ICU) was 16.5 times higher than those followed in the ward (p<0.001). In the multivariate model, this ratio was 6.49. Conclusion: We concluded that FGSI and UFGSI scores could be used to predict mortality. Management of FG requires a multidisciplinary approach. Empiric treatment should include carbapenems and be de-escalated once getting the culture results. Authors from different centers should report their experiences to help reveal the ideal treatment and evaluate the consequences. Keywords: Fournier’s gangrene, necrotizing fasciitis, severity index, FGSI, UFGSI
- 1 January 2022
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 39 (1) , 164-168
Effects of COVID-19 pandemic on management of acute cholecystitis: A single tertiary center's experience
Following the spread of novel coronavirus (COVID-19) pandemic, surgical associations have issued their different recommendations for managing the acute cholecystitis (AC) clinic during the pandemic. We aimed to examine the effects of the COVID-19 pandemic period on our clinical approach in patients who presented to the emergency department with abdominal pain and were diagnosed with AC. Medical records of patients diagnosed with AC in the emergency room between 11 March 2020 and 10 March 2021 and in the same period of one year before the pandemic were retrospectively reviewed. Patients were divided into 2 groups as COVID-19 period (Group 1) and non-COVID period (Group 2). Demographics and clinical characteristics, treatment modalities, and outcomes of these two groups were compared. The number of patients diagnosed with AC in the emergency department decreased during the ongoing COVID-19 pandemic. When the time between the onset of the complaints and the admission to the emergency service was evaluated, no statistically significant difference was found between the groups (p>0.05). The distribution of cholecystitis type and TG18 severity grading for AC were similar in both groups (p>0.05). While percutaneous cholecystostomy (PC) is more preferred in the treatment of AC during the pandemic period and the number of delayed interval laparoscopic cholecystectomy decreased, AC management was similar in both periods with no significant statistical difference (P>0.05). In conclusion, our clinical approach and management in the treatment of AC did not differ when compared to the pre-pandemic period.
- 1 January 2022
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 39 (1) , 164-168
Effects of COVID-19 pandemic on management of acute cholecystitis: A single tertiary center's experience
Following the spread of novel coronavirus (COVID-19) pandemic, surgical associations have issued their different recommendations for managing the acute cholecystitis (AC) clinic during the pandemic. We aimed to examine the effects of the COVID-19 pandemic period on our clinical approach in patients who presented to the emergency department with abdominal pain and were diagnosed with AC. Medical records of patients diagnosed with AC in the emergency room between 11 March 2020 and 10 March 2021 and in the same period of one year before the pandemic were retrospectively reviewed. Patients were divided into 2 groups as COVID-19 period (Group 1) and non-COVID period (Group 2). Demographics and clinical characteristics, treatment modalities, and outcomes of these two groups were compared. The number of patients diagnosed with AC in the emergency department decreased during the ongoing COVID-19 pandemic. When the time between the onset of the complaints and the admission to the emergency service was evaluated, no statistically significant difference was found between the groups (p>0.05). The distribution of cholecystitis type and TG18 severity grading for AC were similar in both groups (p>0.05). While percutaneous cholecystostomy (PC) is more preferred in the treatment of AC during the pandemic period and the number of delayed interval laparoscopic cholecystectomy decreased, AC management was similar in both periods with no significant statistical difference (P>0.05). In conclusion, our clinical approach and management in the treatment of AC did not differ when compared to the pre-pandemic period.
- Open Access
- 31 August 2021
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 7 (2) , 186-191
Recurrence of Hepatic Hydatidosis: How and Why?
Objective: For recurrence of hepatic hydatid, cysts overlooked during surgery, secondary cysts due to the spread of cystic fluid, late postoperative hydatid cyst formation and inadequate treatment are recommended. Factors affecting recurrence were investigated in cases with recurrence. In this retrospective study, data on 199 patients with hepatic hydatid disease treated by surgery in our hospital, between January 1993 and December 2018 were reviewed.Methods: In this study, patients who were operated for hepatic hydatid disease; The relationship between cyst diameters, cyst stages, number of cysts and recurrence was investigated.Results: 84 patients were male and 115 were female. Most of the cases (189 patients- 88.06 %) treated by conservative surgical methods. Remaining’s (8 patients-4.3 %) had total cystectomy or segmental hepatectomy. Recurrence rate was found 5.47%. In that cases, primary operations were done by us, there was no significant differences between cysts’ stages and recurrences. There was not significantly differences between cysts’ number and recurrences, except the patients had 2 cysts (z=2.17, p=0.03).Conclusion: The best way of prevention of the recurrence of hepatic hydatid cysts are complete diagnosis of cysts' classification, localization, and medico-surgical combination. Perioperative medical treatment must be start three days ago before the operation and should be continued for at least 6 months.
- 31 August 2021
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 7 (2) , 186-191
Open AccessRecurrence of Hepatic Hydatidosis: How and Why?
Objective: For recurrence of hepatic hydatid, cysts overlooked during surgery, secondary cysts due to the spread of cystic fluid, late postoperative hydatid cyst formation and inadequate treatment are recommended. Factors affecting recurrence were investigated in cases with recurrence. In this retrospective study, data on 199 patients with hepatic hydatid disease treated by surgery in our hospital, between January 1993 and December 2018 were reviewed.Methods: In this study, patients who were operated for hepatic hydatid disease; The relationship between cyst diameters, cyst stages, number of cysts and recurrence was investigated.Results: 84 patients were male and 115 were female. Most of the cases (189 patients- 88.06 %) treated by conservative surgical methods. Remaining’s (8 patients-4.3 %) had total cystectomy or segmental hepatectomy. Recurrence rate was found 5.47%. In that cases, primary operations were done by us, there was no significant differences between cysts’ stages and recurrences. There was not significantly differences between cysts’ number and recurrences, except the patients had 2 cysts (z=2.17, p=0.03).Conclusion: The best way of prevention of the recurrence of hepatic hydatid cysts are complete diagnosis of cysts' classification, localization, and medico-surgical combination. Perioperative medical treatment must be start three days ago before the operation and should be continued for at least 6 months.
- Open Access
- 1 January 2020
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 3 (1) , 6-17
Effects of evening primrose oil and 5-fluorouracil on the healing of colonic anastomoses in rats
- 1 January 2020
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 3 (1) , 6-17
Open AccessEffects of evening primrose oil and 5-fluorouracil on the healing of colonic anastomoses in rats
- 9 November 2019
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (4) , 795-803
Efficacy of Ultrasound and Shear Wave Elastography for the Diagnosis of Breast Cancer–Related Lymphedema
Objectives: To assess the feasibility of ultrasound and shear wave elastography (SWE) in the diagnosis of breast cancer–related lymphedema.Methods: Forty‐one patients with a history of unilateral breast surgery and axillary dissection or sentinel lymph node excision were included in this prospective study. The patients were classified as having normal findings, latent lymphedema, and clinical lymphedema on the basis of a physical examination, lymphedema index scores, and limb circumference measurements. The thickness and stiffness of the cutaneous and subcutaneous tissue of the forearm and arm were measured by ultrasound and SWE. The thickness and stiffness of the cutaneous and subcutaneous tissue of the affected limb and contralateral limbs of the normal, latent lymphedema, and clinical lymphedema groups were compared.Results: The mean age ± SD of the 41 patients was 55.42 ± 10.12 years. There were 15 patients with normal findings, 10 with latent lymphedema, and 16 with clinical lymphedema. In the latent lymphedema group, the thickness measurements of the cutaneous tissue of the affected forearm and the cutaneous and subcutaneous tissue of the affected arm were significantly greater than those of the contralateral forearm and arm (P = .034; P = .022; and P = .002, respectively), and the stiffness measurements of the cutaneous and subcutaneous tissue of the affected forearm were significantly greater than those of the contralateral forearm (P = .011; and P = .002). In the clinical lymphedema group, the thickness and stiffness measurements of the cutaneous and subcutaneous tissue of the affected forearm and arm were significantly greater than those of the contralateral limb (P < .001–P = .032).Conclusions: Ultrasound and SWE are effective for diagnosing breast cancer–related lymphedema even at a latent stage.
- 9 November 2019
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (4) , 795-803
Efficacy of Ultrasound and Shear Wave Elastography for the Diagnosis of Breast Cancer–Related Lymphedema
Objectives: To assess the feasibility of ultrasound and shear wave elastography (SWE) in the diagnosis of breast cancer–related lymphedema.Methods: Forty‐one patients with a history of unilateral breast surgery and axillary dissection or sentinel lymph node excision were included in this prospective study. The patients were classified as having normal findings, latent lymphedema, and clinical lymphedema on the basis of a physical examination, lymphedema index scores, and limb circumference measurements. The thickness and stiffness of the cutaneous and subcutaneous tissue of the forearm and arm were measured by ultrasound and SWE. The thickness and stiffness of the cutaneous and subcutaneous tissue of the affected limb and contralateral limbs of the normal, latent lymphedema, and clinical lymphedema groups were compared.Results: The mean age ± SD of the 41 patients was 55.42 ± 10.12 years. There were 15 patients with normal findings, 10 with latent lymphedema, and 16 with clinical lymphedema. In the latent lymphedema group, the thickness measurements of the cutaneous tissue of the affected forearm and the cutaneous and subcutaneous tissue of the affected arm were significantly greater than those of the contralateral forearm and arm (P = .034; P = .022; and P = .002, respectively), and the stiffness measurements of the cutaneous and subcutaneous tissue of the affected forearm were significantly greater than those of the contralateral forearm (P = .011; and P = .002). In the clinical lymphedema group, the thickness and stiffness measurements of the cutaneous and subcutaneous tissue of the affected forearm and arm were significantly greater than those of the contralateral limb (P < .001–P = .032).Conclusions: Ultrasound and SWE are effective for diagnosing breast cancer–related lymphedema even at a latent stage.
- Open Access
- 9 August 2012
- Published by Wiley in Case Reports in Surgery
- Vol. 2012, 1-3
Recurrent Bilateral Breast Abscesses after Sternotomy
Median sternotomy is the most commonly used incision in cardiothoracic procedures. Development of breast abscess after sternotomy is a very rare situation. We present a case of sternal wound infection with recurrent bilateral breast abscess after sternotomy. Our case is the first and only case in the literature due to the presence of sternal wound infection with recurrent bilateral breast abscess after sternotomy.
- 9 August 2012
- Published by Wiley in Case Reports in Surgery
- Vol. 2012, 1-3
Open AccessRecurrent Bilateral Breast Abscesses after Sternotomy
Median sternotomy is the most commonly used incision in cardiothoracic procedures. Development of breast abscess after sternotomy is a very rare situation. We present a case of sternal wound infection with recurrent bilateral breast abscess after sternotomy. Our case is the first and only case in the literature due to the presence of sternal wound infection with recurrent bilateral breast abscess after sternotomy.